Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Engensis (donaperminogene seltoplasmid) - Beijing Northland, Reyon Pharma, Helixmith

http://clinicaltrials.gov/ct2/show/NCT04055090

Aug 25, 2021